The recommended dose is:
Adults and adolescents over 12 years old
Generally, one vaginal capsule administered preferably at night before going to bed is sufficient. The vaginal capsule must be inserted deeply into the vagina (see applicator usage instructions), with the patient lying on her back and her legs slightly bent.
If symptoms persist after completing treatment or recur within two months or if you have problems with your immune system, HIV infection, AIDS, or diabetes, you must consult your doctor.
Pregnant women
In case of treatment in the last 4-6 weeks of pregnancy, it is recommended not to use the applicator and insert the vaginal capsule directly with your finger, after careful washing of your hands.
USAGE INSTRUCTIONS
USAGE INSTRUCTIONS FOR THE APPLICATOR 1.Pull the plunger A to the top. Place the vaginal capsule inside the applicator B. 2.Insert the applicator with the vaginal capsule as deeply as possible into the vagina (preferably with the patient lying down). 3.Pull the plunger A to the top, which will deposit the vaginal capsule at the bottom of the vagina. Remove the applicator. |
INSERTION OF THE VAGINAL CAPSULE WITHOUT APPLICATOR Warning Pregnant women must strictly follow the administration instructions given by their doctor. |
If you use more Gine-Canestén than you should
An accidental ingestion may cause gastrointestinal discomfort and/or vomiting. An accidental administration in the eyes may cause burning and eye irritation without severity.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service. Telephone (91) 562 04 20 indicating the medication and the amount ingested.
Like all medications, Gine-Canestén may produce adverse effects, although not everyone will experience them.
Adverse reactions withunknown frequency (cannot be estimated from available data)are:
Immune System Disorders:
Angioedema (swelling under the skin), allergic reaction, hypersensitivity.
Vascular Disorders:
Syncope (sudden loss of consciousness, fainting), hypotension (low blood pressure).
Respiratory, Thoracic, and Mediastinal Disorders:
Difficulty breathing.
Gastrointestinal Disorders:
Abdominal pain, nausea.
Skin and Subcutaneous Tissue Disorders:
Rash,, urticaria (raised, red, itchy hives).
Reproductive and Mammary System Disorders:
Vaginal desquamation, vaginal discharge, vulvovaginal pruritus, vulvovaginal erythema, sensation of burning in the genital area, vulvovaginal discomfort, vulvovaginal pain, and vaginal bleeding.
General and Local Systemic Disorders:
Irritation at the application site, edema, pain.
These symptoms usually do not require discontinuation of treatment and are more frequent during the first days of treatment.
Reporting Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use: http;//www.notificaram.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication
Store in the original packaging to protect it from moisture
Keep this medication out of the sight and reach of children.
Do not use Gine-Canestén after the expiration date that appears on the packaging, after the abbreviation CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medications you no longer need at the Sigre Point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.
Composition of Gine-Canestén
- The active ingredient is clotrimazol. Each vaginal capsule contains 500 mg of clotrimazol.
-The other components (excipients) are: White soft paraffin, liquid paraffin, gelatine, glycerol (E-422), purified water, titanium dioxide (E-171), yellow quinoline (E-104), yellow-orange S (E-110), lecithin, medium-chain triglycerides
Appearance of the product and contents of the packaging:
This medication is a yellow-colored vaginal capsule in the shape of a drop.It is presented in packaging that contains 1 vaginal capsule and a vaginal applicator.
Holder of the marketing authorization
BAYER HISPANIA, S.L.
Av. Baix Llobregat, 3 – 5
08970 Sant Joan Despí (Barcelona)
Spain
Responsible for manufacturing
GP Grenzach Produktions GMBH
Emil-Barrel-Strasse 7
79639 Grenzach-Whylen
Germany
Dateofthelastreviewofthisleaflet:March 2022
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.